What amount sold does SafeMeds Solutions LLC report in Form D filings?

The latest linked filings report $1.4M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was SafeMeds Solutions LLC's most recent SEC filing?

SafeMeds Solutions LLC's most recent Form D filing was on 2013-02-15.

How many investors does SafeMeds Solutions LLC have?

The most recent Form D filing lists 3 investor(s).

What type of securities does SafeMeds Solutions LLC offer?

SafeMeds Solutions LLC's SEC Form D filings indicate equity, debt offerings.

SafeMeds Solutions LLC

CIK: 0001477298·Pharmaceuticals·Ridgeland, MS·Limited Liability Company·Founded 2009

Reported Sold

$1,405,066

Total Filings

Identified Offerings

Last Filed

Feb 15, 2013

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Feb 15, 2013Form D — New notice

Reported sold: $242,602 · Target: $650,000

Rule 506·3 investors

Oct 30, 2012Form D/A — Amendment

Reported sold: $229,964 · Target: $600,000

Rule 506·8 investors

Changed: Reported amount sold, Reported investors

Mar 21, 2012Form D — New notice

Reported sold: $27,237 · Target: $600,000

Rule 506·2 investors

Apr 7, 2011Form D — New notice

Reported sold: $232,500 · Target: $465,000

Rule 505·1 investor·Rule 506

Nov 24, 2009Form D — New notice

Reported sold: $700,000 · Target: $2,000,000

Rule 506·4 investors

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

20%

Latest reported sold across 4 identified offerings

$1,405,066

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

William M Mounger, II

Related Person

Appears on 2 filings

John S. Morris

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 15, 2013	New	$650,000	$242,602	3
Oct 30, 2012	Amendment	$600,000	$229,964	8
Mar 21, 2012	New	$600,000	$27,237	2
Apr 7, 2011	New	$465,000	$232,500	1
Nov 24, 2009	New	$2,000,000	$700,000	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

EpiVario Inc.

Pharmaceuticals

Offering target: $500,000

Filed Oct 13, 2026